Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction

Circulation

Volumn 113, Issue 25, 2006, Pages 2919-2928

  Lindsey, Merry L ^a,e   Escobar, G Patricia ^a   Mukherjee, Rupak ^b   Goshorn, Danielle K ^b   Sheats, Nina J ^b   Bruce, James A ^b   Mains, I Matthew ^b   Hendrick, Jennifer K ^b   Hewett, Kenneth W ^b   Gourdie, Robert G ^b   Matrisian, Lynn M ^c   Spinale, Francis G ^b,d  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Infarction; Leukocytes; Metalloproteinases; Myocardial infarction; Remodeling

Indexed keywords

CONNEXIN 43; GAP JUNCTION PROTEIN; MATRILYSIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORRELATION ANALYSIS; ELECTRIC CONDUCTIVITY; ELECTROCARDIOGRAM; ENZYME INDUCTION; ENZYME SUBSTRATE COMPLEX; FEMALE; HEART CONDUCTION; HEART DILATATION; HEART INFARCTION; HEART VENTRICLE VOLUME; MALE; MOUSE; NONHUMAN; PR INTERVAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; SURFACE PLASMON RESONANCE; SURVIVAL; SURVIVAL RATE; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; CELL JUNCTION; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAPHY; GENE DELETION; GENETICS; HEART BLOCK; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CELL COMMUNICATION; CONNEXIN 43; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC CONDUCTIVITY; ELECTROCARDIOGRAPHY; GAP JUNCTIONS; GENE DELETION; HEART BLOCK; HEART CONDUCTION SYSTEM; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MATRIX METALLOPROTEINASE 7; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN BINDING; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; VENTRICULAR REMODELING;

EID: 33747131851     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.612960     Document Type: Article

References (36)

1. Weber KT. Extracellular matrix remodeling in heart failure. Circulation. 1997;96:4065-4082.
2. Velazquez EJ, O'Connor CM. Heart failure after myocardial infarction: a good heart is hard to find. Am Heart J. 1999;138(pt 1):1009-1011.
3. Lindsey ML. MMP induction and inhibition in myocardial infarction. Heart Fail Rev. 2004;9:7-19.
4. Furman C, Copin C, Kandoussi M, Davidson R, Moreau M, McTaggiart F, Chapman MJ, Fruchart J-C, Rouis M. Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability. Atherosclerosis. 2004;174:93-98.
5. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest. 2000;105:143-150.
6. Boixel C, Fontaine V, Rucker-Martin C, Milliez P, Louedec L, Michel JB, Jacob MP, Hatem SN. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat. J Am Coll Cardiol. 2003;42:336-344.
7. Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem. 2001;276:28261-28267.
8. von Bredow DC, Nagle RB, Bowden GT, Cress AE. Degradation of fibronectin fibrils by matrilysin and characterization of the degradation products. Exp Cell Res. 1995;221:83-91.
9. Crabbe T, Smith B, O'Connell J, Docherty A. Human progelatinase A can be activated by matrilysin. FEBS Lett. 1994;345:14 -16.
10. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A. 1997;94:1402-1407.
11. Wu J, Biermann M, Rubart M, Zipes DP. Cytochalasin D as excitation-contraction uncoupler for optically mapping action potentials in wedges of ventricular myocardium. J Cardiovasc Electrophysiol. 1998;9:1336-1347.
12. Efimov IR, Cheng YN, Biermann M, Van Wagoner DR, Mazgalev TN, Tchou PJ. Transmembrane voltage changes produced by real and virtual electrodes during monophasic defibrillation shock delivered by an implantable electrode. J Cardiovasc Electrophysiol. 1997;8:1031-1045.
13. Girouard SD, Pastore JM, Laurita KR, Gregory KW, Rosenbaum DS. Optical mapping in a new guinea pig model of ventricular tachycardia reveals mechanisms for multiple wavelengths in a single reentrant circuit. Circulation. 1996;93:603-613.
14. McDonnell JM. Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition. Curr Opin Chem Biol. 2001;5:572-577.
15. Rowe PSN, Garrett IR, Schwarz PM, Carnes DL, Lafer EM, Mundy GR, Gutierrez GE. Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP). Bone. 2005;36:33-46.
16. Yousef ZR, Redwood SR, Marber MS. Postinfarction left ventricular remodeling: a pathophysiological and therapeutic review. Cardiovasc Drugs Ther. 2000;14:243-252.
17. Thomas SP, Kucera JP, Bircher-Lehmann L, Rudy Y, Saffitz JE, Kleber AG. Impulse propagation in synthetic strands of neonatal cardiac myocytes with genetically reduced levels of connexin43. Circ Res. 2003;92:1209-1216.
18. Jalife J, Morley GE, Vaidya D. Connexins and impulse propagation in the mouse heart. J Cardiovasc Electrophysiol. 1999;10:1649-1663.
19. Peters NS, Coromilas J, Severs NJ, Wit AL. disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation. 1997;95:988-996.
20. Matsushita T, Oyamada M, Fujimoto K, Yasuda Y, Masuda S, Wada Y, Oka T, Takamatsu T. Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ Res. 1999;85:1046-1055.
21. Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell. 2002;111:635-646.
22. Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T, Takeshita A. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol. 2003;285:H1229-H1235.
23. Berul CI. Electrophysiological phenotyping in genetically engineered mice. Physiol Genom. 2003;13:207-216.
24. Lerner DL, Beardslee MA, Saffitz JE. The role of altered intercellular coupling in arrhythmias induced by acute myocardial ischemia. Cardiovasc Res. 2001;50:263-269.
25. Feng Q, Lu X, Jones DL, Shen J, Arnold JM. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation. 2001;104:700-704.
26. Barandon L, Couffinhal T, Ezan J, Dufourcq P, Costet P, Alzieu P, Leroux L, Moreau C, Dare D, Duplaa C. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. Circulation. 2003;108:2282-2289.
27. Hwang MW, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, Hara M, Miyamoto T, Touma M, Sasayama S. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol. 2001;38:1546-1553.
28. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, Fishman GI. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res. 2001;88:333-339.
29. Saffitz JE, Kleber AG. Effects of mechanical forces and mediators of hypertrophy on remodeling of gap junctions in the heart. Circ Res. 2004;94:585-591.
30. Severs NJ. Gap junction remodeling in heart failure. J Card Fail. 2002;8(pt 2):S293-S299.
31. Fernandes R, Girao H, Pereira P. High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J Biol Chem. 2004;279:27219-27224.
32. Fishman GI, Hertzberg EL, Spray DC, Leinwand LA. Expression of connexin43 in the developing rat heart. Circ Res. 1991;68:782-787.
33. Liu S, Taffet S, Stoner L, Delmar M, Vallano ML, Jalife J. A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxyl tail length. Biophys J. 1993;64:1422-1433.
34. Barker RJ, Price RL, Gourdie RG. Increased association of ZO-1 with connexin43 during remodeling of cardiac gap junctions. Circ Res. 2002;90:317-324.
35. Barker RJ, Gourdie RG. Connexin interacting proteins. In: De Mello WC, Janse MJ, eds. Heart Cell Coupling and Impulse Propagation in Health and Disease. Boston, Mass: Kluwer; 2003:25-50.
36. Hunter AW, Barker RJ, Zhu C, Gourdie RG. Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion. Mol Biol Cell. 2005;16:5686-5698.